Research to rapidly evaluate interventions on Ebola outbreaks in sub-Saharan Africa
The 'Research to rapidly evaluate interventions on Ebola outbreaks in sub-Saharan Africa' program (HORIZON-JU-GH-EDCTP3-2023-01-04) aims to advance knowledge on Ebola virus disease, with a particular focus on the Sudan virus. This initiative supports research into therapeutics, diagnostics, and social science aspects to enhance patient management, public health response, and epidemic preparedness in Africa. It emphasizes collaborative efforts between European and sub-Saharan African entities.
Who is Funded
The program targets a broad range of entities, including research organizations and businesses, from EU Member States, associated countries, and specific sub-Saharan African nations. Its primary objective is to bolster health security and response capabilities against Ebola, especially the Sudan virus, in sub-Saharan Africa.
What is Funded
This program funds research and innovation activities related to Ebola outbreaks, encompassing clinical development of therapeutics and diagnostics, as well as social science research to enhance public health responses. Projects should focus on advancing knowledge and improving interventions for better epidemic preparedness, particularly for the Sudan virus.
Type and Scope of Funding
The program provides funding in the form of grants, with a maximum contribution of 3,000,000 EUR per project for this specific topic. Four grants are expected to be awarded under this topic, reflecting a significant investment in Ebola research in sub-Saharan Africa. The grant type is a Horizon Action Grant Budget-Based.
Conditions and Requirements
Applicants and beneficiaries must adhere to strict consortium composition rules, ensuring diverse international participation with a mandatory sub-Saharan African partner. Specific obligations regarding exploitation of results, including stewardship and global access plans, are also in place.
Application Procedure
The application process involved a single-stage submission, with proposals undergoing evaluation based on specific award criteria and thresholds. Evaluation results were communicated to applicants after the deadline.
Legal Basis
The funding program is established and governed by comprehensive EU regulations, including the Council Regulation establishing Joint Undertakings under Horizon Europe and various annexes of the Horizon Europe Work Programme.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
3,000,000 €
Allocated Budget:
11,000,000 EUR
Award Channel:
Framework Programme Call
Region:
European Union, Horizon Europe Associated Countries, and sub-Saharan Africa (Burkina Faso, Cameroon, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Kenya, Liberia, Malawi, Mali, Mozambique, Niger, Nigeria, Rwanda, Senegal, South Africa, Tanzania, Uganda, Zambia, Zimbabwe).
Sectors:
Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Social Enterprises, Other
Beneficiaries:
Research and healthcare communities, public health systems, patient communities, vulnerable populations in sub-Saharan Africa.
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction
Funding Provider
Program Level:
European Union
Funding Body:
Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU)
Additional Partners:
African Medicines Agency, Africa Centres for Disease Control and Prevention, World Health Organization - Regional Office for Africa, national public health institutes, regulatory authorities.
Website: